Retrospective analysis of risk factors for thrombotic events due to the use of combined oral contraceptives
- Authors: Khamani N.M.1, Saidova R.A.1, Khamani I.V.1, Mashkova T.Y.1, Egorova E.S.1, Kalashnikova I.S2
-
Affiliations:
- I.M. Sechenov FMSU (Sechenov University)
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: No 6 (2019)
- Pages: 108-114
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248560
- DOI: https://doi.org/10.18565/aig.2019.6.108-114
- ID: 248560
Cite item
Abstract
Full Text
About the authors
Nadina Moktarovna Khamani
I.M. Sechenov FMSU (Sechenov University)
Email: nadinka@list.ru
Researcher, Department of Obstetrics and Gynecology
Ravzat Abdulatipovna Saidova
I.M. Sechenov FMSU (Sechenov University)
Email: saidova.ra@gmail.com
MD, Professor, Department of Obstetrics and Gynecology
Inessa Vasilievna Khamani
I.M. Sechenov FMSU (Sechenov University)
Email: dr.hamani@list.ru
PhD, Associate Professor, Department of Obstetrics and Gynecology
Tamara Yakobovna Mashkova
I.M. Sechenov FMSU (Sechenov University)
Email: iza.62@mail.ru
Associate Professor, Department of Obstetrics and Gynecology
Elena Sergeevna Egorova
I.M. Sechenov FMSU (Sechenov University)
Email: eesdoctor@mail.ru
Associate Professor, Department of Obstetrics and Gynecology
I. S Kalashnikova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
References
- Trenor С.С. 3rd, Chung R.J., Michelson AD., Neufeld E.J., Gordon C.M., Laufer M.R., Emans S.J. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011; 127(2): 347-57.
- Dhont М. History of hormonal contraception. Eur. J. Contracept. Reprod. Health Care. 2010; 15(Suppl. 2): 12-8.
- Макацария А.Д., Саидова Р.А. Гормональная контрацепция и тромбофилические состояния. M.: Триада-Х; 2004. 240с.
- Chen М., Culwell К. Contraception for women with medical problems. Glob. Libr. Women’s Med. 2015. https://doi.org/10.3843/GLQWM.10382.
- Lidegaard O., Edstrom B., Kreiner S. Qral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception. 2002; 65(3): 187-96.
- Suchon P., AlFrouh F., Henneuse A., Ibrahim M., Brunet D., Barthet M.C. et al. Risk factors for venous thromboembolism in women under combined oral contraceptive. Thromb. Haemost. 2016; 115(1): 135-142.
- Hugon-Rodin J., Horellou M., Conard J., Gompel A., Plu-Bureau G. Combined hormonal contraceptives and first venous thrombosis in young french women: impact of thrombotic family history. J. Endocr. Soc. 2017; 1(6): 762-71. https:// doi.org/10.1210/js.2017-00090.
- Макарация А.Д., ред. Тромбогеморрагические осложнения в акушерско-гинекологической практике. Руководство для врачей. M.: МИА; 2011. 1050с.
- Gourdy Р., Bachelot А., Catteau-Jonard S., Christin-Maitre S., Conard J., Fredenrich A. et al. Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology. Ann. Endocrinol. (Paris). 2012; 73(5): 469-87.
- Rott H. Birth control pills and thrombotic risks: differences of contraception methods with and without estrogen. Hamostaseologie. 2019; 39(1): 42-8. https:// doi.org/10.1055/s-0039-1677806.
- Tans G., Vlieg H.A., Thomassen M.C., Curvers J., Bertina R.M., Rosing J. et al. Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. Br. J. Haematol. 2003; 122(3): 465-70.
- Хамани Н.М. Особенности ведения беременности и родов у женщины с гомозиготной мутацией протромбина (Pt Thr165Met) и рецидивирующей ТЭЛА в анамнезе на фоне приема гормональной контрацепции. Акушерство, гинекология и репродукция. 2018; 12(1): 99-104.
- Макацария А.Д., Бицадзе В.О., Акиньшина С.В. Тромбозы и тромбоэмболии в акушерско-гинекологической клинике. M.: МИА; 2007. 1064с.
- Wiegratz I., Lee J.H., Kutschera E., Winkler U.H., Kuhl H. Effect of four oral contraceptives on hemostatic parameters. Contraception. 2004; 70(2): 97-106.
- Bergendal A., Persson I., Odeberg J., Sundstrom A., Holmstrom M., Schulman S. et al. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes. Qbstet. Gynecol. 2014; 124(3): 600-9.
- Макацария А.Д., Хизроева Д.Х., Бицадзе В.О., Акиньшина С.В. Беременность и гомозиготные и сочетанные формы тромофилии у пациенток с тромботическим и акушерским отягощённым анамнезом. Тромбоз, гемостаз и реология. 2016; Приложение 3: 269-70.
- Grimes D.A., Stuart G.S., Levi E.E. Screening women for oral contraception: can family history identify inherited thrombophilias? Qbstet. Gynecol. 2012; 120(4): 889-95.
- Jick H., Jick S.S., Gurewich V., Myers M.W., Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995; 346(8990): 1589-93.
- Vlieg H.A., Helmerhorst F.M., Vandenbroucke J.P, Doggen C.J.M., Rosendaal F.R. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009; 339: b2921, 10.1136/bmj.b2921.
- Lidegaard 0., Nielsen L.H., Skovlund C.W., Skjeldestad F.E., Lokkegaard E. (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study 2001-9. BMJ. 2011; 343: d6423.
- Dinger J., Assmann A., Mohner S. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J. Fam. Plann. Reprod. Health Care. 2010; 36(3): 123-9.